METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Nature Cell Biology

• Publication date

  2022-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41556-021-00835-2PMID 35145225PMCID PMC9070413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence Analysis

  2020cited by this paper
• meCLICK-Seq, a Substrate-Hijacking and RNA Degradation Strategy for the Study of RNA Methylation

  2020cited by this paper
• m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

  2020cited by this paper
• Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.

  2020cited by this paper
• Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally

  2019cited by this paper
• METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.

  2019cited by this paper
• The interactome of a family of potential methyltransferases in HeLa cells

  2019cited by this paper
• Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens

  2019cited by this paper
• RNA N6-methyladenosine modification in cancers: current status and perspectives

  2018cited by this paper
• RNA–protein interaction detection in living cells

  2018cited by this paper
• mRNA Translation Gone Awry: Translation Fidelity and Neurological Disease.

  2018cited by this paper
• Translational Control in Cancer.

  2018cited by this paper
• Interactions, localization, and phosphorylation of the m6A generating METTL3–METTL14–WTAP complex

  2018cited by this paper
• eIF3: a factor for human health and disease

  2018cited by this paper
• Translation deregulation in human disease

  2018cited by this paper
• The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates

  2018cited by this paper
• m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer

  2018cited by this paper
• Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development

  2018cited by this paper
• Structural Basis for Regulation of METTL16, an S-Adenosylmethionine Homeostasis Factor.

  2018cited by this paper
• mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis

  2018cited by this paper
• POSTAR2: deciphering the post-transcriptional regulatory logics

  2018cited by this paper
• RNA modifications modulate gene expression during development

  2018cited by this paper
• R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.

  2018cited by this paper
• m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover

  2017cited by this paper
• MetaPlotR: a Perl/R pipeline for plotting metagenes of nucleotide modifications and other transcriptomic sites

  2017cited by this paper
• Transcriptome-wide measurement of translation by ribosome profiling.

  2017cited by this paper
• Isolation of Newly Transcribed RNA Using the Metabolic Label 4-Thiouridine.

  2017cited by this paper
• m6A Facilitates eIF4F-Independent mRNA Translation.

  2017cited by this paper
• S-Adenosylmethionine Synthesis Is Regulated by Selective N6-Adenosine Methylation and mRNA Degradation Involving METTL16 and YTHDC1.

  2017cited by this paper
• The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention.

  2017cited by this paper
• Variant Review with the Integrative Genomics Viewer.

  2017cited by this paper
• Human METTL16 is a N6‐methyladenosine (m6A) methyltransferase that targets pre‐mRNAs and various non‐coding RNAs

  2017cited by this paper
• Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells

  2017cited by this paper
• IRFinder: assessing the impact of intron retention on mammalian gene expression

  2017cited by this paper
• METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.

  2017cited by this paper
• Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation

  2017cited by this paper
• Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer.

  2016cited by this paper
• deepTools2: a next generation web server for deep-sequencing data analysis

  2016cited by this paper
• Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing.

  2016cited by this paper
• Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases.

  2016cited by this paper
• Structural basis of N6-adenosine methylation by the METTL3–METTL14 complex

  2016cited by this paper
• Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA

  2016cited by this paper
• The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.

  2016cited by this paper
• Targeting the translation machinery in cancer

  2015cited by this paper
• Structure of mammalian eIF3 in the context of the 43S preinitiation complex

  2015cited by this paper
• eIF3 targets cell proliferation mRNAs for translational activation or repression

  2015cited by this paper
• FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis

  2014cited by this paper
• Molecular Architecture of the 40SeIF1eIF3 Translation Initiation Complex.

  2014cited by this paper
• Molecular Architecture of the 40S⋅eIF1⋅eIF3 Translation Initiation Complex

  2014cited by this paper
• A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package.

  2014cited by this paper
• Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase

  2014cited by this paper
• Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.

  2014cited by this paper
• STAR: ultrafast universal RNA-seq aligner

  2013cited by this paper
• A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

  2013cited by this paper
• Principles of translational control: an overview.

  2012cited by this paper
• Cutadapt removes adapter sequences from high-throughput sequencing reads

  2011cited by this paper
• Molecular signatures database (MSigDB) 3.0

  2011cited by this paper
• RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

  2011cited by this paper
• Translational control in cancer

  2010cited by this paper
• In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons

  2010cited by this paper
• Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

  2009cited by this paper
• SUnSET, a nonradioactive method to monitor protein synthesis

  2009cited by this paper
• Detecting protein–protein interactions by far western blotting

  2007cited by this paper
• eIF3: a versatile scaffold for translation initiation complexes.

  2006cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper

• Novel N6-methyladenosine (m6A) writer METTL16 promotes the cervical cancer tumorigenesis by targeting FTH1-dependent ferroptosis

  2026cites this paper
• Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA

  2026cites this paper
• Inhibitory effects of METTL3 on airway smooth muscle cell proliferation and migration via lncRNA GAS5/miR-29c-3p/VAMP2 axis.

  2026cites this paper
• Exogenous Epstein–Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy

  2026cites this paper
• METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/β-Catenin Signaling

  2026cites this paper
• METTL16 Modulates GPX4 Expression to Regulate Chondrocyte Ferroptosis.

  2026cites this paper
• METTL16 improves cigarette smoking-induced COPD emphysema through inhibiting autophagy by mediating pri-miR-511 m6A modification.

  2026cites this paper
• Visceral obesity-induced METTL27 regulation of the FABP5/PPARD/CPT1A axis in promoting colorectal cancer progression.

  2026cites this paper
• The methyltransferase METTL16 in digestive system cancers: functions and mechanisms

  2026cites this paper
• Research progress on m6A RNA methylation modification in human reproduction related diseases

  2025cites this paper
• The complex Post-transcriptional Regulation of Genes coding for Methionine Adenosyl Transferase: New insights for liver cancer.

  2025cites this paper
• The role of m6A methylation in abdominal aortic aneurysms: Mechanisms, progress and future perspectives (Review)

  2025cites this paper
• METTL16 Contributes to Coronary Heart Disease by Inducing TET2 m6A Modification

  2025cites this paper
• m6A methylation modification of RNA plays a significant role in the occurrence and development of colorectal cancer.

  2025cites this paper
• METTL16 in cancer: Roles and regulatory mechanisms

  2025cites this paper
• WDR4 drives tumour-associated macrophage reprogramming and tumour progression via selective translation and membrane cholesterol efflux

  2025cites this paper
• METTL16 suppresses ferroptosis in cholangiocarcinoma by promoting ATF4 via m6A modification

  2025cites this paper
• The Oncogenic Role of UBXN1 in Gastric Cancer Is Attributed to the METTL16‐Mediated m6A Methylation and Histone Modifications

  2025cites this paper
• eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification

  2025cites this paper
• The m6A modification of SOX18 leads to increased PTX3 and cardiomyocyte pyroptosis in sepsis-induced cardiomyopathy

  2025cites this paper
• The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma

  2025cites this paper
• METTL3-mediated m6A modification regulates muscle development by promoting TM4SF1 mRNA degradation in P-body via YTHDF2.

  2025cites this paper
• METTL16/IGF2BP2 axis enhances malignant progression and DDP resistance through up-regulating COL4A1 by mediating the m6A methylation modification of LAMA4 in hepatocellular carcinoma

  2025cites this paper
• Effects of m6A methylation of MAT2A mRNA regulated by METTL16 on learning and memory, hippocampal synaptic plasticity and Aβ1–42 in 5 × FAD mice

  2025cites this paper
• The regulatory role of m6A in cancer metastasis

  2025cites this paper
• Methyltransferase-like 16 drives diabetic nephropathy progression via epigenetic suppression of V-set pre-B cell surrogate light chain 3.

  2025cites this paper
• SSB cooperates with METTL16-mediated m6A RNA methylation to promote chemoresistance in colorectal cancer cells

  2025influential citation
• Reciprocal regulation between m6 A modifications and non-coding RNAs: emerging roles in cancer therapeutic resistance

  2025cites this paper
• EIF3B-METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer

  2025influential citation
• RNA m6A modification: a key regulator in normal and malignant processes

  2025cites this paper
• A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein.

  2025cites this paper
• Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities

  2025cites this paper
• METTLING in the pathogenesis of metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• m6A readers: Promising therapeutic targets in cancer treatment

  2025cites this paper
• YTHDF2 regulates self non-coding RNA metabolism to control inflammation and tumorigenesis

  2025cites this paper
• Shenqi Tiaoshen Formula attenuates COPD through METTL16-dependent m6A regulation of MALT1-NF-κB.

  2025cites this paper
• Multi-omics and experimental validation identify methylation-related genes and METTL16 as key regulators in diabetic foot ulcer pathogenesis

  2025cites this paper
• N6-Methyladenosine: an RNA modification as a central regulator of cancer

  2025cites this paper
• RNA modifications: roles in immune cell biology and tumor regulation

  2025cites this paper
• m6A mRNA Methylation in Hematopoiesis: The Importance of Writing, Erasing, and Reading

  2025cites this paper
• [Role of m6A methylation modification in photoaging and ultraviolet-induced skin cancers].

  2025cites this paper
• RNA methyltransferase METTL16: from molecular mechanisms to therapeutic prospects in cancers.

  2025cites this paper
• Interplay of m6A RNA methylation and gut microbiota in modulating gut injury

  2025cites this paper
• m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs

  2025cites this paper
• RNA methylation modifications in neurodegenerative diseases: Focus on their enzyme system

  2025cites this paper
• RNA modifications in cancer

  2025cites this paper
• Small-Molecule Inhibitors Targeting RNA m6A Modifiers for Cancer Therapeutics: Latest Advances and Future Perspectives.

  2025cites this paper
• NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner

  2025cites this paper
• Role of METTL16 in PPARγ methylation and osteogenic differentiation

  2025cites this paper
• Methionine in embryonic development: metabolism, redox homeostasis, epigenetic modification and signaling pathway

  2025cites this paper
• METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis

  2025cites this paper
• PRPS2 enhances RNA m6A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms

  2025cites this paper
• Emerging role of RNA m6A modifications in laryngeal squamous cell carcinoma: insights into tumorigenesis and therapeutic potential

  2025cites this paper
• Epigenetic regulation in oogenesis and fetal development: insights into m6A modifications

  2025cites this paper
• Understanding the Molecular Basis of Miller–Dieker Syndrome

  2025cites this paper
• Non-Histone Lysine Lactylation: Emerging Roles in Tumor Biology and Therapeutic Implications.

  2025cites this paper
• METTL16 accelerates lung adenocarcinoma progression by inducing N6-methyladenosine modification of GTSE1 to regulate p53 pathway and cell cycle

  2025cites this paper
• Nuclear m6A modification regulates satellite transcription and chromosome segregation.

  2025cites this paper
• Unveiling the dynamics and therapeutic potential of m6A methyltransferases and demethylases in liver diseases

  2025cites this paper
• N6-methyladenosine (m6A) RNA methylation: a potential clinical therapeutic target in cardiocerebrovascular diseases.

  2025cites this paper
• Non-histone lactylation: unveiling its functional significance

  2025cites this paper
• Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond.

  2025cites this paper
• Epitranscriptome‐Mediated Regulation of Neuronal Translation

  2025cites this paper
• The catalytic efficiency of METTL16 affects cellular processes by governing the intracellular S-adenosylmethionine setpoint

  2025cites this paper
• Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications

  2025cites this paper
• Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development.

  2025cites this paper
• Structures and mechanisms of U6 snRNA m6A modification by METTL16

  2025cites this paper
• The role of N6-methyladenosine (m6A) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential

  2025cites this paper
• Mutational Analysis Reveals Functional Roles of METTL16 Domains and Residues

  2025cites this paper
• METTL13 Promotes Pre-Leukemic Transformation and the Development of Pediatric Leukemia

  2025cites this paper
• Deciphering the m6A Epitranscriptomic Landscape of mRNAs in Breast Cancer Cells

  2025cites this paper
• Functional Nucleic Acid-Based Biosensing for m6A-modifying Enzyme Activity Monitoring

  2025cites this paper
• Macrophage WTAP Deficiency Protects Atherosclerosis by Improving Macrophage Apoptosis in an m6A‐Independent Manner

  2025cites this paper
• RM2Target v2.0: an updated database for the target genes of writers, erasers, and readers of RNA modifications

  2025cites this paper
• METTL16 emerges as a pivotal epitranscriptomic regulator, linking RNA modification, tumor progression, and immune modulation

  2025cites this paper
• Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia

  2025cites this paper
• YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis

  2024cites this paper
• METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation

  2024cites this paper
• RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives

  2024cites this paper
• METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis

  2024cites this paper
• Understanding YTHDF2-mediated mRNA Degradation By m6A-BERT-Deg

  2024cites this paper
• METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway

  2024cites this paper
• RNA m6A methylation regulators in liver cancer

  2024cites this paper
• New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma

  2024cites this paper
• METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism

  2024cites this paper
• The impact of epitranscriptomic modifications on liver disease.

  2024cites this paper
• N6-methyladenosine in 28S rRNA promotes oncogenic mRNA translation and tyrosine catabolism.

  2024cites this paper
• N6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunity

  2024cites this paper
• METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism.

  2024cites this paper
• WTAP Regulates SOX1 Expression to Affect the Tumorigenicity of Colorectal Cancer via an m6A-YTHDF2-Dependent Manner

  2024cites this paper
• METTL3 improves the development of somatic cell nuclear transfer embryos through AURKB and H3S10ph in goats.

  2024cites this paper
• m6A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription

  2024cites this paper
• N6‐Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases

  2024cites this paper
• Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review)

  2024cites this paper
• Multi-Omics Approach Reveals Genes and Pathways Affected in Miller-Dieker Syndrome

  2024cites this paper
• SERRATE drives phase separation behaviours to regulate m6A modification and miRNA biogenesis

  2024cites this paper
• Overexpression of HYOU1 is associated with cisplatin resistance and may depend on m6A modification in patients with cervical cancer

  2024influential citation
• Regulation of m6A (N6-Methyladenosine) methylation modifiers in solid cancers

  2024cites this paper
• m6A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression.

  2024cites this paper
• Unraveling the landscape of m6A RNA methylation in wound healing and scars

  2024cites this paper